Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric surgical oncology

E S Wiener1

  • 1Department of Pediatric Surgery, Children's Hospital of Pittsburgh, PA 15213-2583.

Current Opinion in Pediatrics
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Surgeons play a vital role in treating childhood cancers by focusing on local tumor control and supportive care. Complete surgical resection remains crucial for improving survival rates in most pediatric solid tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

Sarcoma·2008
Same author

Lessons learned from a failed multi-institutional randomized controlled study.

Journal of pediatric surgery·2002
Same author

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

Journal of pediatric hematology/oncology·2002
Same author

Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?

Seminars in pediatric surgery·2001
Same author

Issues in the local control of rhabdomyosarcoma.

Medical and pediatric oncology·2000

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Childhood Cancer Research

Background:

  • The surgeon's role is central to managing childhood solid tumors, encompassing local control, research contributions, and essential surgical supportive care.
  • Multidisciplinary approaches are increasingly important, with trends favoring neoadjuvant therapies like chemotherapy and, less commonly, radiotherapy before surgical resection.

Purpose of the Study:

  • To delineate the multifaceted role of surgeons in pediatric oncology, emphasizing local tumor control, research, and supportive care strategies.
  • To review the impact of neoadjuvant treatments on surgical resection outcomes for various pediatric solid tumors.
  • To discuss the indications and limitations of surgical interventions in specific pediatric malignancies like lymphoma and germ cell tumors.

Main Methods:

Related Experiment Videos

  • Review of current surgical practices and outcomes in pediatric solid tumors, including neuroblastoma, hepatoblastoma, bone tumors, and nephroblastoma.
  • Analysis of the role of neoadjuvant chemotherapy and radiotherapy in facilitating less extensive, function-preserving resections.
  • Evaluation of surgical management strategies for non-Hodgkin's lymphoma, germ cell tumors, and liver tumors, including transplantation.
  • Discussion of critical supportive care aspects, such as venous access device selection and management of complications like typhlitis.

Main Results:

  • Neoadjuvant therapies can enable safer, delayed resections for certain tumors (e.g., neuroblastoma, hepatoblastoma), potentially preserving organ function without compromising outcomes.
  • Complete surgical resection is a significant determinant of survival for most pediatric solid tumors, even advanced neuroblastomas.
  • Organ transplantation offers a viable option for achieving complete resection in unresectable liver tumors.
  • Surgical resection is generally not recommended for non-Hodgkin's lymphoma, except in specific localized cases.
  • Totally implantable venous access devices demonstrate superior efficacy in preventing dislodgement and reducing infection rates.

Conclusions:

  • Surgeons are indispensable in pediatric oncology, contributing significantly to tumor control, research, and patient well-being.
  • Careful patient selection and judicious use of neoadjuvant therapies can optimize surgical outcomes and functional preservation.
  • Continued research, particularly utilizing neuroblastoma models, is essential for advancing novel treatment modalities in childhood cancer.